The Lumina Pathway
Lumina Medtech supports innovators across the full Australian market journey. Our pathway is designed to reduce risk early, align regulatory and commercial decisions, and build sustainable growth.
OPPORTUNITY
Detailed market assessment and feasibility study to validate the Australian potential.
READINESS
Aligning quality systems, clinical evidence, and regulatory strategies for TGA submission.
APPROVAL
Navigating the regulatory process and securing market access with the TGA.
LAUNCH
Strategic market entry, hospital credentialing, and targeted KOL engagement.
GROWTH
Sustainable commercial management and ongoing market share expansion.
Regulatory, quality and clinical rigor underpin every stage — enabling confidence, credibility and long-term adoption.
What Makes Lumina Different
EARLY INVOLVEMENT
We start at the market assessment phase, not just after approval, preventing costly strategic pivots later.
HONEST ADVICE
If the data suggests the Australian opportunity is limited, we tell you early - before you commit significant resources.
DIRECT SENIOR ACCESS
You work directly with our founders. Our experience is your asset.
FLEXIBLE ENGAGEMENT
From pure consultancy and TGA sponsorship to full outsourced distribution, we scale with your needs.